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Introduction: Rapid and profound BMD loss occur in the
ﬁrst year after allogeneic stem cell transplantation (SCT) and
attributed to steroid exposure, chronic GVHD (cGVHD),
conditioning, age and gender. However, changes in BMD in
very long-term survivors are not well understood. We eval-
uated survivors by serial DEXA scans to determine the ki-
netics as well as to identify the factors inﬂuencing long-term
BMD beyond 3 years post SCT.
Patients and Methods: 148 subjects (85 male and 63 fe-
male) underwent HLA-identical sibling SCT between 1993
and 2011. 58 survivors were informative at 10+ years and 19
at 15+ years. The median age at transplant was 36 years.
Diagnoses at transplant included CML (62), AML/MDS (56),
ALL (16), NHL/CLL (8) and others (6). 88% patients received
12-13 Gy TBI-based conditioning followed by an ex vivo T cell
depleted SCT while 12% received reduced intensity condi-
tioning and a T replete graft. The graft source was peripheral
blood in 133 (90%) andmarrow in 15(10%) patients. Hormone
replacement (in women), Calcium and vitamin D were
routinely supplemented but bisphosphonates were avoided.
Survivors were categorized by their lowest T-score as normal
BMD ( -1), osteopenia (< -1 and > -2.5) or osteoporosis (
-2.5) (WHO criteria). A T-score < -1.0 was deﬁned as bone
loss (BL). Univariate and multivariable analyses were con-
ducted to evaluate the time-trend in BMD, the trends inFigure 1.proportions of subjects with BL and the inﬂuence of age,
gender, conditioning intensity, cGVHD, prolonged cGVHD
(requiring systemic immunosuppression at 3 years), a diag-
nosis of ALL, and body mass index (BMI).
Results: At the start of analysis (3 years post SCT), signiﬁcant
BL had already occurred in 75%: 56 % had osteopenia and 19%
were osteoporotic. The forearm and spine followed by the
femur were the most common sites of osteoporosis. Follow-
up DEXA scans at 5+, 10+ and 15+ years showed signiﬁcant
changes in % with BL and in T-scores (Figure 1). The lowest T-
scores and BMD at various sites showed signiﬁcant increases
between 5 and 10 years. The femoral neck had the lowest
BMD between 5 and 15 years, signiﬁcantly lower (p<0.05)
compared to other sites apart from the forearm.
In multivariable analyses for BMD loss and osteoporosis,
bone loss was more severe with increasing age and lower
BMI but was not inﬂuenced by gender, any history of cGVHD,
prolonged cGVHD, intensity of conditioning regimen, pri-
mary diagnosis (ALL vs other) or stem cell source.
Conclusions: BMD stabilized between 3 and 5 years and
gradually improved between 5-15 years in our long-term
survivors without bisphosphonates. The femoral neck is an
anatomical site that remained vulnerable to prolongeddecline
in BMD. Age and BMI (reﬂecting general health or nutritional
status, Figure 2) weremore inﬂuential in long-term survivors
than variables indicating tissue injury, cGVHD or steroids.214
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Introduction: Metabolic syndrome could be a complication
of HSCT. Several mechanisms, including conditioning
regimen-mediated damage to the neurohormonal system
